Dr. Mian is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1221 Mercantile Ln
301
Upper Marlboro, MD 20774
Education & Training
- National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 2016 - 2019
- University of Texas Health Science Center at Houstonn/a, General Internal Medicine Fellowship, 2015 - 2016
- University of Texas Health Science Center at HoustonResidency, Internal Medicine, 2012 - 2015
- Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 2012, MD
Certifications & Licensure
- VA State Medical License 2020 - 2026
- MD State Medical License 2016 - 2025
- DC State Medical License 2020 - 2024
- TX State Medical License 2015 - 2017
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 89 citationsInherited predisposition to malignant mesothelioma and overall survival following platinum chemotherapyRaffit Hassan, Betsy Morrow, Anish Thomas, Tom Walsh, Ming K. Lee
Proceedings of the National Academy of Sciences of the United States of America. 2019-04-30 - 508 citationsReview of hepatocellular carcinoma: Epidemiology, etiology, and carcinogenesis.Yezaz A. Ghouri, Idrees Mian, Julie H. Rowe
Journal of Carcinogenesis. 2017-01-01 - 23 citationsPhase 2 Study of Olaparib in Malignant Mesothelioma and Correlation of Efficacy With Germline or Somatic Mutations in BAP1 Gene.Azam Ghafoor, Idrees Mian, Cathy Wagner, Yvonne Mallory, Maria Agra
JTO Clinical and Research Reports. 2021-10-01
Journal Articles
- Review of hepatocellular carcinoma: Epidemiology, etiology, and carcinogenesis.Yezaz Ghouri , Idrees Mian, Julie Rowe, Journal of carcinogenesis, 2017
- Prolonged survival with a longer duration of maintenance lenalidomide after autologous hematopoietic stem cell transplantation for multiple myelomaIdrees Mian MD Denái R. Milton MS Nina Shah MD Yago Nieto MD, PhD Uday R. Popat MD Partow Kebriaei MD Simrit Parmar MD Betul Oran MD Jatin J. Shah MD Elisabet ..., Cancer, 9/2016
- Milk Alkali Syndrome: A Consequence of Addiction to Betel Nut ChewingNeel Shah, Lavanya Sendos, Idrees Mian, AACE Clinical Case Reports, 1/1/2016
- Join now to see all
Abstracts/Posters
- Inherited predisposition to malignant mesothelioma (MM) due to mutations in DNA repair genesRaffit Hassan, Betsy Morrow, Tom Walsh, Ming K. Lee, James Gao, Idrees Mian, Javed Khan, American Society of Clinical Oncology, Chicago, 6/2018
- Immune-related adverse events and survival in elderly patients with melanoma treated with ipilimumab.Idrees Mian , MD; Ming Yang; Hui Zhao; Mohsin Shah, MD; Adi Diab, MD; Vickie Shannon, MD; Aneesha Patel MD; Rodabia Amaria, MD; Sharon Giordano, MD; Maria Suarez-Almoz..., American Society of Clinical Oncology, Chicago, 6/2016
- Tick-borne illness causing Hemophagocytic lymphohistiocytosisSarah Kazzaz , Idrees Mian, Sameer Baba, Wafi Momin, Harinder Juneja, Texas Chapter of ACP Meeting, Houston TX, 1/1/2015
- Join now to see all
Lectures
- Effect of Timing and Duration of Maintenance Lenalidomide in Myeloma Patients after Autologous Stem Cell TransplantationsSan Francisco CA - 1/1/2014
- Vision For All: The Establishment Of A Vision Screening Program For Primary Schools In The Northern Himalayan Region Of KashmirDenver, CO - 1/1/2011
Reviews
Well explained result .
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: